Trial intelligence / Profile preview

Pentacel vs. Prevnar administration order and pain response

NCT00390130Phase 4Completed

Sponsor
SickKids
Start
Jul 2006
Primary completion
Jun 2007
Modality
Split/Subunit Vaccines
Countries
1
01

Overview

A Phase 4 trial of Bordetella pertussis toxoid antigen (glutaraldehyde inactivated), pneumococcal 7-valent conjugate vaccine in diphtheria, Tetanus, pertussis, poliomyelitis, Haemophilus influenzae type b infection (Hib), sponsored by SickKids. Started Jul 2006; status: completed.

02

Drugs

Bordetella pertussis toxoid antigen (glutaraldehyde inactivated)pneumococcal 7-valent conjugate vaccine
03

Conditions

diphtheriaTetanuspertussispoliomyelitisHaemophilus influenzae type b infection (Hib)

Beyond the preview

Go deeper on NCT00390130.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00390130.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call